1.Reoperation for postoperative recurrent gastric carcinoma
Shouchun ZOU ; Zhiming HU ; Chengwu ZHANG ; Dajian ZHAO ; Houquan TAO ; Ting ZHAO ; Wei JIANG
Chinese Journal of General Surgery 2001;0(09):-
Objective To evaluate the clinical significance of re operation for postoperative recurrent gastric carcinoma. Methods From 1986 to 2001, fifty one patients with postoperative local recurrence of gastric carcinoma were admitted into our hospital. The clinical data were analyzed retrospectively. Results Of 51 cases, there were 31 cases with recurrence within the stump stomach and 20 with local and metastatic recurrence. Twenty seven cases were treated by radical resection, 3 cases by palliative residual stomach resection, 15 cases by gastrojejunostomy or gastroenterostomy, 6 cases by simple exploration. Pathological examination of 30 cases revealed perianastomosis recurrence in 10 cases, stump stomach carcinoma in 20 cases. The 1,3,5 year survival rate of 27 cases after radical resection was 88%, 58%, 19% respectively. The survival time of palliative and comprehensive treatment group was 6 to 24 months and mean survival time was 16 months, while all patients undergoing simple exploration and abdominal cavity chemotherapy died after 2 to 7 months. Conclusion Most postoperative recurrent gastric carcinoma are within the residual stomach and hence could be treated by reoperative resection.
2.Progress of Listeria monocy togenes as tumor vaccine vector
Feifei DUAN ; Yuelan YIN ; Meiqin KANG ; Weijun TAN ; Chengwu TAO ; Zhiming PAN ; Jinlin HUANG ; Xinan JIAO
Chinese Journal of Zoonoses 2014;(7):743-746,752
Listeriamonocytogenes is a facultative intracellular bacterium that enters professional antigen presenting cells , presents passenger antigens to the major histocompatibility complex class I and II pathways ,then elicits CD+4 and CD+8 T-cell-mediated immune responses .It was demonstrated that attenuated Listeriamonocytogenes as a novel live vaccine vector in deliv-ering tumor antigens of cervical cancer and melanoma etc .,could induce strong protective immune response ,and shows effec-tive antitumor immunotherapeutics .This review discussed the characteristics of immune responses elicited by Listeria monocy-togenes ,and the progress of its antitumor immunotherapeutics as delivery vaccine vector .
3.Neutrophil phenotypes in peripheral blood of neonates with late-onset sepsis
Junyan HAN ; Yun CAO ; Xiaoming ZHANG ; Chengwu TAO ; Shujuan LI
Chinese Journal of Perinatal Medicine 2019;22(5):316-323
Objective To investigate the changes in neutrophil immunophenotypes in neonates with late-onset sepsis and their clinical significance.Methods A total of 42 neonates with late-onset sepsis were enrolled prospectively as sepsis group from Children's Hospital of Fudan University from January 2015 to October 2016,which included 26 preterm infants and 16 term infants.Another 33 neonates without infectious diseases consisting of 20 preterm infants and 13 term infants were selected as control group.According to the severity of sepsis,neonates in the sepsis group were further divided into severe (n=11)and mild sepsis (n=31) subgroups.Expression of CD16 and CD62L on neutrophils was measured by flow cytometry to determine the distribution of neutrophil subsets in neonatal peripheral blood.Differences in the distribution of neutrophil subsets between the two groups and two subgroups were compared using Wilcoxon rank-sum test.Multivariate logistic regression analysis was used to investigate the relationship between neutrophil subsets and the severity of neonatal sepsis.Receiver operating characteristic (ROC) curves were used to assess the diagnostic value of neutrophil subsets for the severity of sepsis.Results Four neutrophil subsets were identified in neonatal peripheral blood,including early-stage neutrophils (CD16-/CD62L-),immature neutrophils (CD16-/CD62L+),mature neutrophils (CD16+/CD62L+) and activated neutrophils (CD16+/CD62L-).Activated [preterm:61.1% (20.2%-79.4%),term:47.6% (15.2%-70.1%)] and mature neutrophils [preterm:35.7% (19.9%-75.8%),term:52.0% (25.6%-82.8%)] were the dominant subsets in the control group.In preterm infants,the proportion of early-stage [3.5% (1.7%-9.4%) vs 1.9% (0.6%-4.0%),Z=-2.501,P=0.012] and immature neutrophils [6.3% (0.7%-45.5%) vs 0.4% (0.3%-0.7%),Z=-3.878,P<0.001] were higher,but that of activated neutrophils [8.3% (2.3%-49.2%) vs 61.1% (20.2%-79.4%),Z=2.991,P=0.002] were lower in the sepsis group than those in the control group;same differences were found in the absolute counts of each neutrophil subsets.Among term infants,more immature neutrophils were found in the sepsis group than those in the control group [49 (18-200) vs 13 (5-36)/μl,Z=-2.193,P=0.028].The proportion and the absolute counts of early-stage and immature neutrophils in the severe sepsis subgroup were all higher than those in the mild cases [early-stage neutrophils:5.8% (3.4%-17.8%) vs 3.0% (1.4%-7.3%),304 (137-1478) vs 158 (53-321)/μl;immature neutrophils:23.0% (6.3%-47.0%) vs 0.9% (0.5%-6.8%),1003 (487-2818) vs 85 (18-275)/μl;all P<0.05].Multivariate logistic regression analysis showed that the proportion of early-stage neutrophils was associated with the severity of sepsis (OR=1.2,95%CI:1.0-1.4,P=0.012).In addition,the diagnostic value of the proportion of early-stage neutrophils for severe sepsis was the highest when the cut-off value was 3.3%,with the area under the ROC curve was 0.7 (95%CI:0.6-0.9),sensitivity of 81.8% (95%CI:48.2%-97.7%) and specificity of 62.3% (95%CI:42.2%-78.2%).Conclusions There are four neutrophil subsets in the peripheral blood of neonates and autoactivation of neutrophils may exist.With the onset of sepsis,neutrophil subsets react differently between preterm and term infants.The proportion of early-stage neutrophils may be correlated with the severity of neonatal sepsis,which may have a predictive value for severe sepsis.
4.Clinical efficacy of atezolizumab plus bevacizumab in the first-line treatment of advanced hepatocellular carcinoma
Yi LU ; Junwei LIU ; Guoliang SHEN ; Junfa CHEN ; Tingyang HU ; Haijun HUANG ; Ran TAO ; Chengwu ZHANG
Chinese Journal of Digestive Surgery 2021;20(S2):25-28
Primary hepatic carcinoma has ranked as the sixth most commonly diagnosed cancer and the third leading cause of cancer death. China shares about 50% of new liver cancer cases, including 80% of hepatic carcinoma. Non-surgical therapy continues to make breakthroughs. The authors report a case of hepatic carcinoma with intrahepatic metastasis and tumor thrombus in the left portal vein, which has achieved continious partial response after the treatment of atezoli-zumab combined with bevacizumab, without adverse reactions such as liver and kidney function damage. The life quality of the patient was improved, showing safety and efficacy of the treatment.